ArticleFrontiers in oncology2026
Case Report: Gastrointestinal cancer initially presenting as postmenopausal osteoporosis.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gastric cancer usually presents late with nonspecific symptoms such as epigastric discomfort, anorexia, weight loss, nausea, anemia, or gastrointestinal bleeding. Initial presentation with osteoporosis-like manifestations and multiple bone metastases in the absence of gastrointestinal symptoms is rare. Case presentation: We report a 59-year-old postmenopausal woman who presented with thoracolumbar back pain after routine activity. Bone mineral density assessment showed osteoporosis, but laboratory evaluation revealed markedly increased bone turnover markers, including alkaline phosphatase, β-CTX, and P1NP. Because these findings were disproportionate to typical primary postmenopausal osteoporosis, secondary osteoporosis and other metabolic bone disorders were further investigated. Whole-body bone scintigraphy, SPECT/CT, and PET/CT demonstrated multiple osteoblastic skeletal lesions suggestive of metastatic disease. Gastrointestinal endoscopy subsequently identified two synchronous primary tumors: a poorly differentiated gastric adenocarcinoma with focal signet-ring cell differentiation and a moderately differentiated sigmoid colon adenocarcinoma. Bone biopsy confirmed metastatic adenocarcinoma of gastrointestinal origin, most likely from the stomach. No definite extraosseous visceral metastases were identified on imaging. Discussion: This case illustrates that disseminated gastric cancer may rarely present without gastrointestinal symptoms and may initially mimic postmenopausal osteoporosis, particularly when bone pain coexists with markedly elevated bone turnover markers. It also highlights the importance of a multidisciplinary diagnostic approach in patients initially suspected of primary osteoporosis but showing atypical biochemical or imaging findings. Clinicians should remain alert to secondary osteoporosis, including occult malignancy, in such settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.